Riskpilot← Back to searchSign inGet full accessInnovacc AB
ABActiveOrg 5592998438Skogshejdevägen 74-21Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 20211 employees
Revenue 2024
SEK 4K
EBITDA margin
-257.4%
+86% vs 2023
Equity ratio
-539.8%
Financial strength
Net profit 2024
SEK -11K
+82% vs 2023
| Revenue | SEK 4K | — |
| EBITDA | SEK -10K | +86% |
| Net profit | SEK -11K | +82% |
| Total assets | SEK 1K | -90% |
| Equity | SEK -7K | -276% |
| Employees | 1 | — |
Legal name
Innovacc AB
Org number
5592998438
Legal form
Aktiebolag
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
3 februari 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall erbjuda medicinska tester och undersökningar för diagnostik, hälso- och behandlingskontroll, hälsoplanering, rådgivning och därmed förenlig verksamhet.
Address
Skogshejdevägen 74-21
Phone
+46709131813
Email
maria@innovacc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 871 | 2 280 | 0 | 4 |
| Staff expenses | — | −675 | −13 | −1 |
| EBITDA | 6 | 59 | −74 | −10 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 6 | 59 | −74 | −10 |
| Net financials | −1 | −0 | 0 | −0 |
| Profit before tax | 5 | 44 | −59 | −11 |
| Tax | −2 | −9 | — | — |
| Net profit | 3 | 35 | −59 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 634 | 135 | 13 | 1 |
| Equity | 28 | 63 | 4 | −7 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 1 606 | 58 | 9 | 8 |
| Total debt | 1 606 | 58 | 9 | 8 |
EBITDA margin
-257.4%
This company
15.8%
Market median
-1729% vs market
20212024
Equity ratio
-539.8%
This company
38.2%
Market median
-1513% vs market
20212024
Return on equity
-1054600.0%
This company
18.4%
Market median
-5731622% vs market
20212024
Net profit margin
-269.6%
This company
8.1%
Market median
-3428% vs market
20212024
Asset turnover
3.14×
This company
1.12×
Market median
+180% vs market
20212024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (7) | ||
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Innovacc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrica Elisabeth Branning | Chairman | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Nils Olof Jarlman | Board of Directors | 0 companies |
| Anders Patrick Larsén | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Agnes Maria Carolina Hedberg | Board of Directors | 0 companies |
| Ebba Amelie Jarlman | Deputy Board Member | 0 companies |